Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. [electronic resource]
Producer: 20000313Description: 885-90 p. digitalISSN:- 0898-6568
- Carcinoma, Hepatocellular -- pathology
- Cell Movement -- drug effects
- Chromones -- pharmacology
- Cycloheximide -- pharmacology
- Enzyme Inhibitors -- pharmacology
- Flavonoids -- pharmacology
- Hepatocyte Growth Factor -- pharmacology
- Humans
- Liver Neoplasms -- pathology
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Mitogen-Activated Protein Kinases -- metabolism
- Morpholines -- pharmacology
- Neoplasm Proteins -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- physiology
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation -- drug effects
- Protein Processing, Post-Translational -- drug effects
- Protein Synthesis Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- physiology
- Proto-Oncogene Proteins c-cbl
- Tetradecanoylphorbol Acetate -- pharmacology
- Tumor Cells, Cultured -- drug effects
- Ubiquitin-Protein Ligases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.